The objective of this acquisition is to identify the true scope of metal-implant related adverse health outcomes. The effort will require multiple sources of demographic, clinical and…
Ended Purchase Order Awarded Last action
- Contract number
- 75F40120P00254
- Awardee
-
Loopback, L.L.C. UEI HDH1Z18VEV74
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $249,555
Award facts
- Opportunity
-
- Access to Inpatient Hospital Drug Utilization Data Pre-Solicitation · FDARFP20201229385 · Posted Jan 27, 2020
- Access to Inpatient Hospital Drug Utilization Data Solicitation · Posted Jun 14, 2020
- Contract value 100% obligated
- $249,555.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621111 Offices of Physicians (except Mental Health Specialists)
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Dallas, TX 75254, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $249,555 |
About this award
This federal contract award was issued by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Loopback, L.L.C., a small business, for $249,555.00 on a firm fixed-price basis. The objective is to identify the true scope of metal-implant related adverse health outcomes, which will require analyzing multiple sources of demographic, clinical and epidemiological real-world data (RWD) on adverse outcomes. This award appears to be related to a previous pre-solicitation for an instrument that offers high throughput quantification of binding kinetics parameters for monoclonal antibodies (mAbs) and other proteins in solution phase measurements, such as an Octet RED96e system brand name or equal to. The contract has a total small business set-aside designation.
Description
The objective of this acquisition is to identify the true scope of metal-implant related adverse health outcomes. The effort will require multiple sources of demographic, clinical and epidemiological real-world data (RWD) on adverse outcomes in relat
Quick answers
Who was awarded contract 75F40120P00254?
75F40120P00254 was awarded to Loopback, L.L.C. by Food and Drug Administration (Department of Health and Human Services) on August 11, 2020.
How much is contract 75F40120P00254 worth?
The government has obligated $249,555 on 75F40120P00254.
Was contract 75F40120P00254 competed?
The extent of competition for 75F40120P00254 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award